(Q63228900)

English

The Use of PatientReportedOutcomes (PRO)- CTCAE by Melanoma Patients Receiving Immunotherapy

clinical trial

Statements

The Use of PRO-CTCAE by Patients Receiving Immunotherapy for the Treatment of Malignant Melanoma (English)
0 references
0 references
10 January 2017
0 references
May 2019
0 references
140
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit